Skip to main content

Animations

MJFF Publications

6321 - 6330 of 8816 Results
Title
Year
  • Year
  • 2022
  • 2025
  • 2018
  • 2014
  • 2018
  • 2025
  • 2025
  • 2025
  • 2021
  • 2018
  • Summary Details
    OPEN
    Title: More of less: Novel multi-ome profiling of single human neurons
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Structure based design, synthesis and identification of novel covalent reversible dual TLR2/TLR9 small molecule antagonists
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2025.130259
    Citation Count: 0
  • Summary Details
    OPEN
    Title: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040
    Citation Count: 609
  • Summary Details
    RESTRICTED
    Title: 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice
    Journal Name: Neuroscience Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neures.2014.11.005
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Response to letter to the Editor: The association between cigarette smoking and dementia with Lewy bodies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107895
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01159-w
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The Progressive Supranuclear Palsy Clinical Deficits Scale accurately reflects functional as well as patient- and caregiver-reported outcomes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108060
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddab188
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Stimulation-induced reversed plus-minus syndrome: Insights into eyelid physiology
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.04.010
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.